Wang Ruihan, Kan Yuanqing, Yang Mou, Zhang Hongkun, Zhang Xiaoming, Dai Xiangchen, Zhai Shuiting, Hu Hejie, Zhang Xiwei, Chen Bing, Huang Jianhua, Qin Xiao, Xiao Zhanxiang, Lu Xinwu, Guo Wei, Si Yi, Fu Weiguo
Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Vascular Surgery, Yantai Yuhuangding Hospital Affiliated With Qingdao University, Yantai, China.
Front Cardiovasc Med. 2022 Feb 14;9:817675. doi: 10.3389/fcvm.2022.817675. eCollection 2022.
To report the clinical outcomes and aortic remodeling after the implantation of a self-developed, biomechanically optimized, two-stage thoracic stent system named Fabulous.
Given the efficacy of the PETTICOAT concept, the benefits of Fabulous and the behavior of remodeling in different segments need further investigation.
This is a prospective and multicenter study. From 2017 to 2019, 145 patients (mean age, 56.6 years; 88.3% male) from 14 centers were included in this cohort. The clinical results and core laboratory results were from a central electronic data capture system. Computed tomographic angiography was performed preoperatively, 1 month, 6 months and yearly thereafter and was used for volumetric analysis by 3mensio (Bilthoven, The Netherlands). After the 1-year follow-up, 97.2 and 87.6% of the clinical and imaging results of the eligible patients were available.
Both stent grafts and bare stents were successfully delivered in place in 100% of the patients. The 30-day mortality and 1-year freedom from all-cause mortality were 2.1 and 96.6%, respectively. The incidence of entry flow was 11.7% at 30 days and 6.2% at 365 days. No cases of stent-induced new entry (SINE) or reintervention were observed. After the 1-year follow-up, the true lumen/overall volume ratio reached 88%. The following subdivided segment volume changes were recorded: stent graft segment TL +56%; FL -92%, bare stent segment TL +32%; FL -75%, and there were no significant changes in the visceral segment.
These outcomes indicated that there were favorable clinical benefits of Fabulous stent system. This device achieved a low short-term mortality and a low incidence of reintervention. In addition, patients undergoing Fabulous stent system implantation showed remodeling both on descending aorta and on the distal aorta. The volume changes in the TL and FL varied in the different segments. The long-term follow-up is still ongoing.
报告一种自主研发的、生物力学优化的两阶段胸段支架系统(名为Fabulous)植入后的临床结果和主动脉重塑情况。
鉴于PETTICOAT概念的有效性,Fabulous的益处以及不同节段的重塑行为需要进一步研究。
这是一项前瞻性多中心研究。2017年至2019年,来自14个中心的145例患者(平均年龄56.6岁;88.3%为男性)纳入该队列。临床结果和核心实验室结果来自中央电子数据采集系统。术前、术后1个月、6个月及此后每年进行计算机断层血管造影,并通过3mensio(荷兰比尔瑟姆)进行容积分析。1年随访后,97.2%和87.6%的符合条件患者的临床和影像结果可用。
100%的患者支架型人工血管和裸支架均成功到位。30天死亡率和1年全因死亡率分别为2.1%和96.6%。30天时入口血流发生率为11.7%,365天时为6.2%。未观察到支架诱导的新入口(SINE)或再次干预病例。1年随访后,真腔/总体积比达到88%。记录了以下细分节段的容积变化:支架型人工血管节段真腔增加56%;假腔减少92%,裸支架节段真腔增加32%;假腔减少75%,内脏节段无显著变化。
这些结果表明Fabulous支架系统具有良好的临床益处。该装置实现了较低的短期死亡率和较低的再次干预发生率。此外,接受Fabulous支架系统植入的患者在降主动脉和远端主动脉均出现重塑。真腔和假腔的容积变化在不同节段有所不同。长期随访仍在进行中。